6569

Onyx HealthcareTPEX:6569 Stock Report

Market Cap

NT$3.3b

7D

-1.4%

1Y

-12.7%

Updated

22 Sep, 2021

Data

Company Financials
6569 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends1/6

6569 Overview

Onyx Healthcare Inc., a professional medical IT company, provides medical PC solutions for the hospital/clinical IT market worldwide.

Share Price & News

How has Onyx Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 6569 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 6569's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

-1.4%

6569

-1.9%

TW Healthcare Services

-0.8%

TW Market


1 Year Return

-12.7%

6569

-3.1%

TW Healthcare Services

36.1%

TW Market

Return vs Industry: 6569 underperformed the TW Healthcare Services industry which returned -3.1% over the past year.

Return vs Market: 6569 underperformed the TW Market which returned 36.1% over the past year.


Shareholder returns

6569IndustryMarket
7 Day-1.4%-1.9%-0.8%
30 Day-11.1%14.5%5.6%
90 Day-8.7%-7.1%-0.2%
1 Year-9.0%-12.7%-2.9%-3.1%40.1%36.1%
3 Year50.8%34.4%113.4%112.2%75.1%57.1%
5 Year-10.2%-25.6%207.5%204.1%122.8%85.5%

Long-Term Price Volatility Vs. Market

How volatile is Onyx Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Onyx Healthcare Fundamentals Summary

How do Onyx Healthcare's earnings and revenue compare to its market cap?
6569 fundamental statistics
Market CapNT$3.25b
Earnings (TTM)NT$142.99m
Revenue (TTM)NT$1.25b

22.8x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6569 income statement (TTM)
RevenueNT$1.25b
Cost of RevenueNT$849.63m
Gross ProfitNT$403.54m
ExpensesNT$260.55m
EarningsNT$142.99m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)4.73
Gross Margin32.20%
Net Profit Margin11.41%
Debt/Equity Ratio25.1%

How did 6569 perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

106%

Payout Ratio

Valuation

Is Onyx Healthcare undervalued compared to its fair value and its price relative to the market?

22.75x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 6569 (NT$107.5) is trading above our estimate of fair value (NT$96.9)

Significantly Below Fair Value: 6569 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 6569 is good value based on its PE Ratio (22.8x) compared to the Asian Healthcare Services industry average (51.6x).

PE vs Market: 6569 is poor value based on its PE Ratio (22.8x) compared to the TW market (16.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 6569's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 6569 is good value based on its PB Ratio (3.5x) compared to the XA Healthcare Services industry average (4.8x).


Future Growth

How is Onyx Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Onyx Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Onyx Healthcare performed over the past 5 years?

5.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 6569 has a high level of non-cash earnings.

Growing Profit Margin: 6569's current net profit margins (11.4%) are lower than last year (11.6%).


Past Earnings Growth Analysis

Earnings Trend: 6569's earnings have grown by 5.4% per year over the past 5 years.

Accelerating Growth: 6569's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6569 had negative earnings growth (-2.7%) over the past year, making it difficult to compare to the Healthcare Services industry average (59.3%).


Return on Equity

High ROE: 6569's Return on Equity (15.1%) is considered low.


Financial Health

How is Onyx Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: 6569's short term assets (NT$696.8M) exceed its short term liabilities (NT$449.6M).

Long Term Liabilities: 6569's short term assets (NT$696.8M) exceed its long term liabilities (NT$247.3M).


Debt to Equity History and Analysis

Debt Level: 6569's debt to equity ratio (25.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 6569's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 6569's debt is well covered by operating cash flow (89.6%).

Interest Coverage: 6569 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Onyx Healthcare current dividend yield, its reliability and sustainability?

4.65%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 6569's dividend (4.65%) is higher than the bottom 25% of dividend payers in the TW market (1.93%).

High Dividend: 6569's dividend (4.65%) is low compared to the top 25% of dividend payers in the TW market (5.25%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, 6569 has been paying a dividend for less than 10 years.

Growing Dividend: 6569's dividend payments have increased, but the company has only paid a dividend for 5 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (105.8%), 6569's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.8yrs

Average management tenure


CEO

Yung-Shun Chuang

11.58yrs

Tenure

Mr. Yung-Shun Chuang has been Independent Director at Taiflex Scientific Co., Ltd. since July 16, 2021. Mr. Chuang is Representative Chairman of the Board of Directors of Onyx Healthcare Inc. since May 29,...


Leadership Team

Experienced Management: 6569's management team is seasoned and experienced (7.8 years average tenure).


Board Members

Experienced Board: 6569's board of directors are considered experienced (5.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Onyx Healthcare Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Onyx Healthcare Inc.
  • Ticker: 6569
  • Exchange: TPEX
  • Founded: 2010
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: NT$3.253b
  • Shares outstanding: 30.26m
  • Website: https://www.onyx-healthcare.com

Number of Employees


Location

  • Onyx Healthcare Inc.
  • No.135, Lane 235
  • 2nd Floor
  • New Taipei City
  • 231
  • Taiwan

Listings


Biography

Onyx Healthcare Inc., a professional medical IT company, provides medical PC solutions for the hospital/clinical IT market worldwide. It offers mobile cart computers, ubiquitous power solutions, remote man...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/22 15:23
End of Day Share Price2021/09/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.